Cargando…

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Vassar, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Lecture Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287613/ http://dx.doi.org/10.1186/1750-1326-7-S1-L3

Ejemplares similares

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
por: Annaert, Wim
Publicado: (2012)

Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer's disease
por: Vakilian, Alireza, et al.
Publicado: (2019)

The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
por: Rajapaksha, Tharinda W, et al.
Publicado: (2011)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
por: Ponzoni, Ignacio, et al.
Publicado: (2019)

Gamma-secretase: from pathogenesis to therapeutics
por: Li, Yueming
Publicado: (2012)

Structure-function relationship of γ-secretase
por: Tomita, Taisuke
Publicado: (2012)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016)

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
por: Kandalepas, Patty C., et al.
Publicado: (2013)

The beta secretase BACE1 regulates the expression of insulin receptor in the liver
por: Meakin, Paul J., et al.
Publicado: (2018)

Erratum to: The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
por: Kandalepas, Patty C., et al.
Publicado: (2013)

Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1
por: Mycroft-West, Courtney J., et al.
Publicado: (2021)

β - but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

Electrochemical Detection of Alzheimer’s Disease Biomarker, β-Secretase Enzyme (BACE1), With One-Step Synthesized Reduced Graphene Oxide
por: Dey, Jhilik, et al.
Publicado: (2022)

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease
por: Cole, S.L, et al.
Publicado: (2007)

A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)

Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase
por: Scholefield, Zoe, et al.
Publicado: (2003)

Repression of Alzheimer's beta-Secretase
por: Liao, Francesca-Fang, et al.
Publicado: (2013)

A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018)

Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality
por: Butler, Christopher R., et al.
Publicado: (2016)

BACE1: More than just a β‐secretase
por: Taylor, Hannah A., et al.
Publicado: (2022)

A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease
por: Mycroft-West, Courtney J., et al.
Publicado: (2019)

Regulation of dynamic BACE1 trafficking in neurons
por: Buggia-Prévot, Virginie, et al.
Publicado: (2013)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Inhibition of BACE1, the β-secretase implicated in Alzheimer’s disease, by a chondroitin sulfate extract from Sardina pilchardus
por: Mycroft-West, Courtney J., et al.
Publicado: (2020)

Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics
por: Hemming, Matthew L., et al.
Publicado: (2009)

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
por: Jabir, Nasimudeen R., et al.
Publicado: (2021)

LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking1,2,3
por: Tanokashira, Daisuke, et al.
Publicado: (2015)

Gram-Scale Synthesis of a β-Secretase 1 (BACE 1) Inhibitor
por: Allison, Brett D., et al.
Publicado: (2017)

Presenilins in Alzheimer’s disease and frontotemporal dementia
por: Shen, Jie
Publicado: (2012)

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer
por: Sayad, Arezou, et al.
Publicado: (2022)

Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels
por: Youn, Kumju, et al.
Publicado: (2017)

Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
por: Estus, Steven
Publicado: (2012)

Recent developments in tau-based therapeutics for Alzheimer’s disease and related dementsia
por: Medina, Miguel
Publicado: (2015)

Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer’s disease
por: Gozes, Illana
Publicado: (2015)

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
por: Nicsanu, Roland, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rhv1e80stror64ekhdp1o40jkt